BI-WEEKLY DOSING REGIMENS OF IDURONATE-2-SULFATASE ENZYME REPLACEMENT MPS II

艾杜糖酸-2-硫酸酯酶替代品 MPS II 每两周一次的给药方案

• 批准号: 7377468
• 负责人: JOSEPH J. MUENZER
• 金额: $ 1.39万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7377468
• 关键词: BI; WEEKLY; DOSING; REGIMENS; IDURONATE

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is designed to further investigate the effectiveness and safety of this nex experimental treatment for Hunter Syndrome.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。本研究旨在进一步研究这种新的实验性治疗亨特氏综合征的有效性和安全性。